Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 May 1;183(5):2397–2402. doi: 10.1084/jem.183.5.2397

RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells

PMCID: PMC2192590  PMID: 8642352

Abstract

We studied the effects of various chemokines including neutrophil- activating peptide 2 (NAP-2), beta-thromboglobulin (beta-TG), platelet factor 4 (PF-4), melanoma growth stimulating activity (GRO), gamma interferon-induced protein (IP-10), regulated on activation, normal T expressed and secreted (RANTES), macrophage inflammatory protein 1 alpha (MIP-1 alpha), MIP-1 beta, and monocyte chemotactic protein 1 (MCP-1) on Immunoglobulin (IgE) and IgG4 production by human B cells. None of these chemokines with or without interleukin (IL-4), anti-CD40 or -CD58 monoclonal antibody (mAb), induced IgE and IgG4 production by B cells from nonatopic donors. However, RANTES and MIP-1 alpha selectively enhanced IgE and IgG4 production induced by IL-4 plus anti- CD40 or -CD58 mAb without affecting production of IgM, IgG1, IgG2, IgG3, IgA1, or IgA2, whereas other chemokines failed to do so. Enhancement of IgE and IgG4 production by RANTES and MIP-1 alpha was specifically blocked by anti-RANTES mAb and anti-MIP-1 alpha antibody (Ab), respectively, whereas anti-IL-5 mAb, anti-IL-6 mAb, anti-IL-10 Ab, anti-IL-13 Ab, and anti-tumor necrosis factor-alpha mAb failed to do so. Purified surface IgE positive (slgE4) and slgG4+ B cells generated either in vitro or in vivo spontaneously produced IgE and IgG4, respectively, whereas sIgE- and sIgG4- B cells failed to do so. RANTES and MIP-1 alpha enhanced spontaneous IgE and IgG4 production in slgE+ and slgG4- B cells, respectively, whereas neither RANTES nor MIP- 1 alpha did so in sIgE- or sIgG4- B cells. Purified sIgE4+ and sIgG4+, but not sIgE- or sIgG4- B cells, generated in vitro and in vivo expressed receptors for RANTES and MIP-1 alpha, whereas they failed to express receptors for other chemokines. These findings indicate that RANTES and MIP-1 alpha enhance IgE and IgG4 production by directly stimulating sIgE+ and sIgG4+ B cells.

Full Text

The Full Text of this article is available as a PDF (594.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aversa G., Punnonen J., de Vries J. E. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med. 1993 Jun 1;177(6):1575–1585. doi: 10.1084/jem.177.6.1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Broxmeyer H. E., Sherry B., Cooper S., Lu L., Maze R., Beckmann M. P., Cerami A., Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol. 1993 Apr 15;150(8 Pt 1):3448–3458. [PubMed] [Google Scholar]
  3. Cacalano G., Lee J., Kikly K., Ryan A. M., Pitts-Meek S., Hultgren B., Wood W. I., Moore M. W. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 1994 Jul 29;265(5172):682–684. doi: 10.1126/science.8036519. [DOI] [PubMed] [Google Scholar]
  4. Diaz-Sanchez D., Chegini S., Zhang K., Saxon A. CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. J Immunol. 1994 Jul 1;153(1):10–20. [PubMed] [Google Scholar]
  5. Diaz P., Galleguillos F. R., Gonzalez M. C., Pantin C. F., Kay A. B. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol. 1984 Jul;74(1):41–48. doi: 10.1016/0091-6749(84)90085-x. [DOI] [PubMed] [Google Scholar]
  6. Gao J. L., Kuhns D. B., Tiffany H. L., McDermott D., Li X., Francke U., Murphy P. M. Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J Exp Med. 1993 May 1;177(5):1421–1427. doi: 10.1084/jem.177.5.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gosset P., Tonnel A. B., Joseph M., Prin L., Mallart A., Charon J., Capron A. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol. 1984 Dec;74(6):827–834. doi: 10.1016/0091-6749(84)90186-6. [DOI] [PubMed] [Google Scholar]
  8. Kimata H. Differential effects of gangliosides on human IgE and IgG4 production. Eur J Immunol. 1995 Jan;25(1):302–305. doi: 10.1002/eji.1830250151. [DOI] [PubMed] [Google Scholar]
  9. Kimata H., Fujimoto M. Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J Exp Med. 1994 Aug 1;180(2):727–732. doi: 10.1084/jem.180.2.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kimata H., Fujimoto M., Lindley I., Furusho K. Interleukin 8 (IL-8) inhibits the interleukin 4 (IL-4)-induced but not the spontaneous growth of human B cells via mechanisms that may involve protein kinase C. Biochem Biophys Res Commun. 1995 Feb 27;207(3):1044–1050. doi: 10.1006/bbrc.1995.1290. [DOI] [PubMed] [Google Scholar]
  11. Kimata H., Lindley I. Interleukin-8 differentially modulates interleukin-4- and interleukin-2-induced human B cell growth. Eur J Immunol. 1994 Dec;24(12):3237–3240. doi: 10.1002/eji.1830241250. [DOI] [PubMed] [Google Scholar]
  12. Kimata H., Mikawa H. Nedocromil sodium selectively inhibits IgE and IgG4 production in human B cells stimulated with IL-4. J Immunol. 1993 Dec 15;151(12):6723–6732. [PubMed] [Google Scholar]
  13. Kimata H., Yoshida A. Differential effects of gangliosides on Ig production and proliferation by human B cells. Blood. 1994 Aug 15;84(4):1193–1200. [PubMed] [Google Scholar]
  14. Kimata H., Yoshida A., Fujimoto M., Mikawa H. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol. 1993 May 15;150(10):4630–4640. [PubMed] [Google Scholar]
  15. Kimata H., Yoshida A., Ishioka C., Lindley I., Mikawa H. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J Exp Med. 1992 Oct 1;176(4):1227–1231. doi: 10.1084/jem.176.4.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kimata H., Yoshida A., Ishioka C., Mikawa H. Differential effect of vasoactive intestinal peptide, somatostatin, and substance P on human IgE and IgG subclass production. Cell Immunol. 1992 Oct 15;144(2):429–442. doi: 10.1016/0008-8749(92)90257-p. [DOI] [PubMed] [Google Scholar]
  17. Kimata H., Yoshida A., Ishioka C., Mikawa H. Effect of recombinant human erythropoietin on human IgE production in vitro. Clin Exp Immunol. 1991 Mar;83(3):483–487. doi: 10.1111/j.1365-2249.1991.tb05665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kiniwa M., Gately M., Gubler U., Chizzonite R., Fargeas C., Delespesse G. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest. 1992 Jul;90(1):262–266. doi: 10.1172/JCI115846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meurer R., Van Riper G., Feeney W., Cunningham P., Hora D., Jr, Springer M. S., MacIntyre D. E., Rosen H. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med. 1993 Dec 1;178(6):1913–1921. doi: 10.1084/jem.178.6.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Oppenheim J. J., Zachariae C. O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol. 1991;9:617–648. doi: 10.1146/annurev.iy.09.040191.003153. [DOI] [PubMed] [Google Scholar]
  21. Punnonen J., Aversa G., Cocks B. G., McKenzie A. N., Menon S., Zurawski G., de Waal Malefyt R., de Vries J. E. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3730–3734. doi: 10.1073/pnas.90.8.3730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rodríguez C., Roldán E., Navas G., Brieva J. A. Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Eur J Immunol. 1993 May;23(5):1160–1164. doi: 10.1002/eji.1830230527. [DOI] [PubMed] [Google Scholar]
  23. Rot A., Krieger M., Brunner T., Bischoff S. C., Schall T. J., Dahinden C. A. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med. 1992 Dec 1;176(6):1489–1495. doi: 10.1084/jem.176.6.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schall T. J., Bacon K., Camp R. D., Kaspari J. W., Goeddel D. V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med. 1993 Jun 1;177(6):1821–1826. doi: 10.1084/jem.177.6.1821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990 Oct 18;347(6294):669–671. doi: 10.1038/347669a0. [DOI] [PubMed] [Google Scholar]
  26. Wu C. Y., Sarfati M., Heusser C., Fournier S., Rubio-Trujillo M., Peleman R., Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J Clin Invest. 1991 Mar;87(3):870–877. doi: 10.1172/JCI115092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zhang K., Clark E. A., Saxon A. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol. 1991 Mar 15;146(6):1836–1842. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES